Heidelberg, Germany

Ulrich Hersel

USPTO Granted Patents = 40 

 

Average Co-Inventor Count = 4.9

ph-index = 9

Forward Citations = 325(Granted Patents)


Location History:

  • Fritz-Frey-Strasse, DE (2015)
  • Heidelberg/Hanschuhsheim, DE (2011 - 2018)
  • Heidelberg, DE (2011 - 2024)

Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
40 patents (USPTO):Explore Patents

Title: Ulrich Hersel - Innovator in Pharmaceutical Science

Introduction

Ulrich Hersel, located in Heidelberg, Germany, is a notable inventor with a remarkable portfolio of 37 patents. His innovative contributions are primarily focused on pharmaceutical sciences, particularly in the development of novel therapeutic agents.

Latest Patents

Hersel's recent patents showcase his expertise in creating advanced pharmaceutical compositions. One of his latest inventions is related to "CNP prodrugs with carrier attachment at the ring moiety." This invention involves CNP prodrugs where the carrier is covalently and reversibly bonded to the ring moiety. The resulting compositions have potential applications for treating various diseases.

Another significant patent is for "controlled-release CNP agonists with increased NEP stability." This invention highlights controlled-release CNP agonists with a degradation half-life that is at least five times longer in an in vitro NEP degradation assay compared to the corresponding released CNP agonist. These advancements promise improved therapeutic options and effectiveness in treatment methods.

Career Highlights

Throughout his career, Ulrich Hersel has been associated with notable companies, including Ascendis Pharma A/S and Ascendis Pharma Growth Disorders A/S. His work at these organizations has significantly contributed to the field of pharmaceutical research and development.

Collaborations

Hersel has collaborated with esteemed colleagues such as Harald Rau and Thomas Wegge. This collaborative spirit has driven innovation within their projects, leading to successful advancements in their respective areas of expertise.

Conclusion

Ulrich Hersel continues to be a driving force in pharmaceutical innovation, leveraging his extensive patent portfolio to address critical challenges in medicine. His contributions are not only pivotal for the scientific community but also hold the potential to impact the treatment landscape significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…